Cargando…

Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study

Hepatic myelopathy is a complication seen in patients with chronic liver failure with physiologic or iatrogenic portosystemic shunting. The main symptom is progressive lower limb dyskinesia. The role of the brain motor control center in hepatic myelopathy is unknown. This study aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kang, Chen, Gang, Ren, Shu-Yao, Zhu, Yuan-Qiang, Yu, Tian-Lei, Tian, Ping, Li, Chen, Xi, Yi-Bin, Wang, Zheng-Yu, Ye, Jian-Jun, Han, Guo-Hong, Yin, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375042/
https://www.ncbi.nlm.nih.gov/pubmed/30688271
http://dx.doi.org/10.4103/1673-5374.249233
_version_ 1783395297702969344
author Liu, Kang
Chen, Gang
Ren, Shu-Yao
Zhu, Yuan-Qiang
Yu, Tian-Lei
Tian, Ping
Li, Chen
Xi, Yi-Bin
Wang, Zheng-Yu
Ye, Jian-Jun
Han, Guo-Hong
Yin, Hong
author_facet Liu, Kang
Chen, Gang
Ren, Shu-Yao
Zhu, Yuan-Qiang
Yu, Tian-Lei
Tian, Ping
Li, Chen
Xi, Yi-Bin
Wang, Zheng-Yu
Ye, Jian-Jun
Han, Guo-Hong
Yin, Hong
author_sort Liu, Kang
collection PubMed
description Hepatic myelopathy is a complication seen in patients with chronic liver failure with physiologic or iatrogenic portosystemic shunting. The main symptom is progressive lower limb dyskinesia. The role of the brain motor control center in hepatic myelopathy is unknown. This study aimed to investigate the gray matter changes in patients with hepatic myelopathy secondary to transjugular intrahepatic portosystemic shunt and to examine their clinical relevance. This was a cross-sectional study. Twenty-three liver failure patients with hepatic myelopathy (hepatic myelopathy group), 23 liver failure patients without hepatic myelopathy (non-hepatic myelopathy group) after transjugular intrahepatic portosystemic shunt, and 23 demographically matched healthy volunteers were enrolled from March 2014 to November 2016 at Xijing Hospital, Air Force Military Medical University (Fourth Military Medical University), China. High-resolution magnetization-prepared rapid gradient-echo brain imaging was acquired. Group differences in regional gray matter were assessed using voxel-based morphometry analysis. The relationship between aberrant gray matter and motor characteristics was investigated. Results demonstrated that compared with the non-hepatic myelopathy group, gray matter volume abnormalities were asymmetric, with decreased volume in the left insula (P = 0.003), left thalamus (P = 0.029), left superior frontal gyrus (P = 0.006), and right middle cingulate cortex (P = 0.021), and increased volume in the right caudate nucleus (P = 0.017), corrected with open-source software. The volume of the right caudate nucleus in the hepatic myelopathy group negatively correlated with the lower limb clinical rating of the Fugl-Meyer Assessment (r = –0.53, P = 0.01). Compared with healthy controls, patients with and without hepatic myelopathy exhibited overall increased gray matter volume in both thalami, and decreased gray matter volume in both putamen, as well as in the globus pallidus, cerebellum, and vermis. The gray matter abnormalities we found predominantly involved motor-related regions, and may be associated with motor dysfunction. An enlarged right caudate nucleus might help to predict weak lower limb motor performance in patients with preclinical hepatic myelopathy after transjugular intrahepatic portosystemic shunt. This study was approved by the Ethics Committee of Xijing Hospital, Air Force Military Medical University (Fourth Military Medical University), China (approval No. 20140227-6) on February 27, 2014.
format Online
Article
Text
id pubmed-6375042
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-63750422019-05-01 Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study Liu, Kang Chen, Gang Ren, Shu-Yao Zhu, Yuan-Qiang Yu, Tian-Lei Tian, Ping Li, Chen Xi, Yi-Bin Wang, Zheng-Yu Ye, Jian-Jun Han, Guo-Hong Yin, Hong Neural Regen Res Research Article Hepatic myelopathy is a complication seen in patients with chronic liver failure with physiologic or iatrogenic portosystemic shunting. The main symptom is progressive lower limb dyskinesia. The role of the brain motor control center in hepatic myelopathy is unknown. This study aimed to investigate the gray matter changes in patients with hepatic myelopathy secondary to transjugular intrahepatic portosystemic shunt and to examine their clinical relevance. This was a cross-sectional study. Twenty-three liver failure patients with hepatic myelopathy (hepatic myelopathy group), 23 liver failure patients without hepatic myelopathy (non-hepatic myelopathy group) after transjugular intrahepatic portosystemic shunt, and 23 demographically matched healthy volunteers were enrolled from March 2014 to November 2016 at Xijing Hospital, Air Force Military Medical University (Fourth Military Medical University), China. High-resolution magnetization-prepared rapid gradient-echo brain imaging was acquired. Group differences in regional gray matter were assessed using voxel-based morphometry analysis. The relationship between aberrant gray matter and motor characteristics was investigated. Results demonstrated that compared with the non-hepatic myelopathy group, gray matter volume abnormalities were asymmetric, with decreased volume in the left insula (P = 0.003), left thalamus (P = 0.029), left superior frontal gyrus (P = 0.006), and right middle cingulate cortex (P = 0.021), and increased volume in the right caudate nucleus (P = 0.017), corrected with open-source software. The volume of the right caudate nucleus in the hepatic myelopathy group negatively correlated with the lower limb clinical rating of the Fugl-Meyer Assessment (r = –0.53, P = 0.01). Compared with healthy controls, patients with and without hepatic myelopathy exhibited overall increased gray matter volume in both thalami, and decreased gray matter volume in both putamen, as well as in the globus pallidus, cerebellum, and vermis. The gray matter abnormalities we found predominantly involved motor-related regions, and may be associated with motor dysfunction. An enlarged right caudate nucleus might help to predict weak lower limb motor performance in patients with preclinical hepatic myelopathy after transjugular intrahepatic portosystemic shunt. This study was approved by the Ethics Committee of Xijing Hospital, Air Force Military Medical University (Fourth Military Medical University), China (approval No. 20140227-6) on February 27, 2014. Medknow Publications & Media Pvt Ltd 2019-05 /pmc/articles/PMC6375042/ /pubmed/30688271 http://dx.doi.org/10.4103/1673-5374.249233 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Research Article
Liu, Kang
Chen, Gang
Ren, Shu-Yao
Zhu, Yuan-Qiang
Yu, Tian-Lei
Tian, Ping
Li, Chen
Xi, Yi-Bin
Wang, Zheng-Yu
Ye, Jian-Jun
Han, Guo-Hong
Yin, Hong
Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study
title Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study
title_full Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study
title_fullStr Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study
title_full_unstemmed Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study
title_short Regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study
title_sort regional gray matter abnormality in hepatic myelopathy patients after transjugular intrahepatic portosystemic shunt: a voxel-based morphometry study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375042/
https://www.ncbi.nlm.nih.gov/pubmed/30688271
http://dx.doi.org/10.4103/1673-5374.249233
work_keys_str_mv AT liukang regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy
AT chengang regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy
AT renshuyao regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy
AT zhuyuanqiang regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy
AT yutianlei regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy
AT tianping regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy
AT lichen regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy
AT xiyibin regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy
AT wangzhengyu regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy
AT yejianjun regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy
AT hanguohong regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy
AT yinhong regionalgraymatterabnormalityinhepaticmyelopathypatientsaftertransjugularintrahepaticportosystemicshuntavoxelbasedmorphometrystudy